MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT)*
Attachments
Phathom Pharmaceuticals – Leading the way to innovative treatments for gastrointestinal diseases
Parents
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
*Industry: New Jersey
Children
Finance & Acquisitions: Phantom Pharmaceuticals
Florham Park, New Jersey
Founded 2018
Key People: Phantom Pharmaceuticals
Organization & Developments: Phantom Pharmaceuticals
Jumps
Takeda Pharmaceutical Company Ltd (NYSE:TAK)(OTCPK:TKPHF)